Dual Action Calcium-Sensing Receptor Modulator Unmasks Novel Mode-Switching Mechanism

Karen J Gregory1, Irina Kufareva2, Andrew N Keller1

  • 1Drug Discovery Biology and Department of Pharmacology, Monash Institute of Pharmaceutical Sciences, 381 Royal Parade, Monash University, Parkville, Victoria 3052, Australia.

Insights

Negative allosteric modulators (NAMs) targeting the calcium-sensing receptor (CaSR) exhibit mode-switching behavior. This CaSR NAM can potentiate or inhibit receptor activity, offering new therapeutic strategies.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Structural Biology

Background:

  • Negative allosteric modulators (NAMs) of the calcium-sensing receptor (CaSR) have shown limited success in osteoporosis but are being explored for hypocalcemic and inflammatory lung diseases.
  • The precise mechanisms by which CaSR NAMs inhibit responses to endogenous activators remain incompletely understood.
  • Developing a deeper mechanistic insight into CaSR negative allosteric modulation is crucial for designing improved CaSR-targeting therapeutics.

Purpose of the Study:

  • To elucidate the mechanistic and structural basis of allosteric modulation by the CaSR NAM, calhex231.
  • To investigate how calhex231 interacts with the CaSR dimer to influence receptor activity.
  • To explore the implications of novel allosteric modulation mechanisms for CaSR-targeting drug discovery.

Main Methods:

  • Utilized biochemical assays to assess the activity of CaSR in the presence of calhex231 and various agonists.
  • Employed structural biology techniques to determine the binding modes of calhex231 within the CaSR dimer.
  • Analyzed the functional consequences of calhex231 occupying one versus both protomers of the CaSR dimer.

Main Results:

  • Demonstrated that calhex231 exhibits mode-switching behavior, acting as a potentiator or inhibitor of CaSR activity.
  • Showed that the effect of calhex231 is dependent on its binding stoichiometry within the CaSR dimer (one or both protomers).
  • Identified a novel mechanism of allosteric modulation involving differential protomer occupancy in a Class C G protein-coupled receptor.

Conclusions:

  • Calhex231 displays a unique mode-switching mechanism at the CaSR, challenging previous assumptions about NAM function.
  • This discovery provides a new framework for understanding CaSR allosteric modulation.
  • The findings have significant implications for the rational design of next-generation CaSR-targeting drugs with enhanced therapeutic potential.

Related Concept Videos

Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.9K
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
1.4K
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
3.6K
Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.4K
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
2.9K
Depolarizing Blockers: Mechanism of Action01:28

Depolarizing Blockers: Mechanism of Action

Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
2.5K